AER 1542312, is a spontaneous case, received on 18/Feb/2015, from a physician  and concerns a female patient 
of unspecified age,  who experienced neurological symptoms, blood pressure out of control and progressive 
multifocal leukoencephalopathy  while being  treated with bevacizumab (Avastin).
No medical history, concurrent conditions, concomitant medications or past drugs were reported.
On an unspecified date, the patient started therapy with bevacizumab  (dosing regimen was not reported) for 
metastatic ovarian cancer. Later she experienced neurological symptoms, blood pressure out of control captured 
as (abnormal blood pressure) and progressive multifocal leukoencephalopathy .
At the time of this report, outcome of the events neurological symptoms, blood pressure out of control and 
Print Time: 07-JUN-2016 03:01 PM If a field is blank, there is no data for that field Page 18 of 549
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information
progressive multifocal leukoencephalopathy  was not reported and it was not known if therapy with bevacizumab 
was ongoing or not.
The reporter did not report the causal relationship of the events neurological symptoms, blood pressure out of 
control and progressive multifocal leukoencephalopathy  with bevacizumab .
Company assesed event progressive multifocal leukoencephalopathy  as medically significant.
No further information was provided.